Davide Soldato
@DSoldatoMD
Followers
1K
Following
2K
Media
27
Statuses
158
M.D. | Medical Oncologist | PhD Student at @GustaveRoussy & @UnivParisSaclay | Breast Cancer | Clinical Research | Survivorship
Genova, Liguria
Joined September 2021
Torno da #AIOMGiovani con nuove idee, tanta energia e orgogliosamente convinto di sostenere @delmastro_lucia alla Presidenza AIOM con l’obiettivo di far crescere fattivamente e #INSIEME un’AIOM fondata su innovazione, network, inclusività, mentorship ed eccellenza! 💪🌱.
0
3
10
Termina oggi il Congresso Nazionale #AIOMGiovani 🎓 a Firenze: un'occasione preziosa di confronto, crescita e networking 🤝tra tanti giovani colleghi in tutta Italia organizzato da giovani oncologi per giovani oncologi!
1
0
5
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
494
281
3K
Termina oggi il Congresso Nazionale #AIOMGiovani 🎓 a Firenze: un’occasione preziosa di confronto, crescita e networking 🤝 tra tanti giovani colleghi in tutta Italia organizzato da giovani oncologi per giovani oncologi!
0
0
9
RT @Lucarecco: Beautiful return to @PortoAnticoGe of the #AmerigoVespucci after 2 years on @tourvespucci world tour 🇮🇹🌍🏴. If you visi….
0
6
0
RT @M_Tagliamento: Da oggi al 14 con @AIOMtweet @AiomFondazione @AIRC_it @_sirm saremo al Porto Antico del @ComunediGenova per parlare di #….
0
12
0
RT @matteolambe: È iniziato il congresso nazionale #AIOM24…foto immancabile con la delegazione AIOM Liguria che con orgoglio sosterrà la ca….
0
8
0
Go check out the amazing work led by @Poggio_Fra on efficacy of adjuvant chemotherapy schedules according to BMI!.
Congrats to @Poggio_Fra for this publication in @ESMO_Open. Efficacy of adjuvant chemotherapy schedules for breast cancer according to BMI within the randomized GIM2 trial. Link: @delmastro_lucia @matteolambe @BlondeauxEva @SanMartino_Ge @OncoAlert #bcsm
1
0
15
RT @matteolambe: Presented at #ASCO24 by @Lucarecco and now out in @Annals_Oncology…really grateful to all that have made the #BRCA BCY col….
0
13
0
RT @NEJM: 🧵 Review Article: Key Issues as Wearable Digital Health Technologies Enter Clinical Care . Wearable digital health technologies (….
0
56
0
RT @AliceFranzoi: Sexual concerns are prevalent at BC dx and increase or persist after treatment with <50% of pts receiving support. How….
0
11
0
RT @matteolambe: Presented at #SABCS23 results from #INAVO120 trial showing PFS benefit with the addition of #inavolisib to #fulvestrant an….
0
15
0
RT @Lucarecco: Huge congratulations @matteolambe for leading this massive 🌎 effort reassuring about the safety of pregnancy after BC in you….
0
13
0
RT @BenedettaConte5: Super, incredible @matteolambe at #SABCS23, reporting results from the largest international cohort study on pregnancy….
0
5
0
RT @ZimmTeamLab: Findings of this review of #PalliativeCare RCTs in non-cancer illness suggest that most #PROs of #QoL were neither derived….
0
6
0
RT @CancerCareMASCC: Don't forget to register for our upcoming webinar on Precision Oncology on Nov 13. Speakers: @maryam_lustberg @Kalinsk….
0
7
0
RT @AriellaHanker: 🙌Hey @utswcancer @UTSWCancerBio @UTSWScience @UTSWHemeOnc @utswimmuno @UTSW_Pathology, check out @md_napolitano's semin….
0
6
0
Check out the latest from the amazing @BenedettaConte5! Very important results to undergoing biological mechanisms and adequately select patients for extended HT! Stay tuned! #bcsm @OncoAlert.
🚨🚨 Promising biomarker to select patients for extended adjuvant aromatase inhibitors in patients with #breastcancer 🚨🚨. Article out today in @CCR_AACR.open access. ⬇ Thread follows @matteolambe @prat_aleix @OncoAlert @UniGenova @FrancescoSche20.
0
0
7
RT @matteolambe: The @UniGenova @SanMartino_Ge crew at #ESMO23 🇮🇹❤️🤩💪🔝. @delmastro_lucia @myESMO @OncoAlert @M_Tagliamento @FSpagnoloMD @Ca….
0
15
0
Proud of you @ElenaCroce4! Very relevant topic: early discontinuation of Cemiplimab after response for CSCC appears safe. Need to test discontinuation of IO in trials to reduce financial and toxicity burden!.
Check out the poster of our great colleague @ElenaCroce4 about early discontinuation of Cemiplimab in advanced CSCC. @myESMO @OncoAlert
0
0
11
Super #ESMOYOC brunch: communicate research. 🔸Know your message, tailor to the audience, make the listener “think, feel and do” .❗️Attention span ~8 sec: be compelling.🧠People remember stories more than numbers.Thanks @pawel_sobczuk and @rillepihlak for the amazing session!
2
8
34